SARS-CoV-2 infection in endothelial cells.
- SARS-CoV-2 likely activates endothelial cell responses in patients which contributes to serious lung symptoms, vascular obstruction and respiratory distress with Covid-19.
- A study shows that endothelial cells which line capillaries lack ACE2 receptors for SARS-CoV-2 attachment and suggests that SARS-CoV-2 indirectly activates endothelial cell linked disease mechanisms that direct coagulation and inflammation associated with severe Covid-19 disease.
- As a result, endothelial cell activation and SARS-CoV-2 induced endothelial cell responses may be potential therapeutic targets to help resolve Covid-19 disease.
For Covid-19 patients with serious lung disease, targeting endothelial cells –cells that comprise the blood vessel wall which regulate oxygen exchange between airways and the bloodstream– may be a novel approach restoring normal lung function. This hypothesis stems from a study by researchers in the Department of Microbiology and Immunology in the Renaissance School of Medicine at Stony Brook University and published in mBio, the leading journal for the American Society for Microbiology.
SARS-CoV-2 causes Covid-19, characterized by pulmonary edema, viral pneumonia, coagulopathy, inflammation and other physiological abnormalities. SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) receptors to infect and damage ciliated epithelial vascular cells in the upper respiratory tract. Yet how SARS2 dysregulates vascular functions causing an acute respiratory distress syndrome (ARDS) in Covid-19 patients remains an enigma.
Led by Erich Mackow, PhD, a Professor of Microbiology and Immunology, the team of scientists sought to unravel this mechanism by investigating SARS-CoV-2 infection of human endothelial cells from the lung, brain, heart and kidney that are impacted in COVID-19 patients.
“Claims that endothelial cells are infected by SARS-CoV-2 through ACE2 receptors have never been assessed directly,” said Mackow. “Our research revealed that endothelial cells lack ACE2 receptors and that endothelial cells were only SARS-CoV-2 infected after expressing ACE2 receptors in them. Since endothelial cell functions are dysregualted by SARS-CoV-2, these findings suggest a novel mechanism of regulation that does not require viral infection. Instead it suggests the indirect activation of the endothelium, potentially resulting from surrounding tissue damage, that could be the basis for further research to therapeutically target and restore normal endothelial cell responses.”
Mackow adds that their work centers on both endothelial cells and ACE2 functions in Covid-19 disease to identify mechanisms of capillary inflammation and aberrant clotting within vessels. He explains that the research reveals a novel mechanism of clotting and endothelial inflammation observed in the lung and heart of COVID-19 patients.
“A transformative change in the mechanism of endothelial cell dysfunction, not the infection of the cells themselves, changes the way in which disease is initiated and rationales for therapeutic targeting. If endothelial cells are not infected or directly damaged, they can still direct inflammation and clotting by just being activated,” he concludes from the research findings.
The team is working on how endothelial cells can be activated by the virus or in response to other SARS-CoV-2 infected lung cells that express ACE2.
The research suggests the potential to therapeutically target activation, rather than infection of the endothelium, as a strategy for resolving coagulation and inflammatory Covid-19 symptoms.
Mackow emphasizes that additional research of endothelial cells and down-regulated ACE2 functions following SARS-CoV-2 infection are necessary to determine targets that could lead to a reduction in respiratory distress and symptoms of Covid-19 patients.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Endothelial cell targeting
- United Therapeutics gets grant for apparatus for pancreatic function restoration using membrane with cell systems
Discover United Therapeutics Corp's innovative patent for a blood purification apparatus with vascular and filtration channels. Learn about a groundbreaking method to restore pancreatic function.
- Spanish scientists identify the key cell type for strategies to prevent atherosclerosis in progeria syndrome
Hutchinson-Gilford progeria syndrome (HGPS) is an extremely rare genetic disease that affects just 1 in every 20 million people; it is estimated that fewer than 400 children in the world have the ...
- Low circALMS1 levels could be prognostic biomarker in PH: Study
Low circular RNA Alstrom syndrome protein 1 levels promote higher numbers and migration of pulmonary microvascular endothelial cells.
- Elevated glutamine triggers stroke risk in moyamoya disease via endothelial‐to‐mesenchymal transition, finds study
A study appearing in MedComm has been led by Dr. Jizong Zhao, Dr. Dong Zhang, and Dr. Peicong Ge (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University and Department of ...
- Molecular code stimulates pioneer cells to build blood vessels in the body
Cardiovascular diseases, including stroke and myocardial infarction, are the world's leading causes of mortality, accounting for more than 18 million deaths a year. A team of KIT researchers has now ...
Go deeper with Google Headlines on:
Endothelial cell targeting
[google_news title=”” keyword=”endothelial cell targeting” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Coagulation and inflammatory Covid-19 symptoms
- Indian woman with rare disease treated by Shanghai doctors
A patient from India who was recently received at Shanghai Renij Hospital and obtained medical treatment there after doctors identified her rare disease recovered and was discharged in mid-April, the ...
- Study suggests lingering coronavirus in tissues may contribute to long COVID symptoms
Study investigated whether SARS-CoV-2 lingers in tissues after COVID-19 recovery and if it's linked to long COVID symptoms. They found viral RNA in various organs, and its presence correlated with ...
- Identifying proteins causally related to COVID-19, healthspan and lifespan
A new research paper titled "Using genetics and proteomics data to identify proteins causally related to COVID-19, healthspan and lifespan: a Mendelian randomization study" has been published in Aging ...
- Aging affects immune response and virus dynamics in COVID-19 patients, study finds
A study examining 1031 hospitalized COVID-19 patients found that aging significantly impacts immune responses, viral dynamics, and the nasal microbiome, with older adults experiencing more severe ...
- COVID-19 Linked to Long-Term Risk of Autoimmune Inflammatory Rheumatic Diseases
The risk for incident autoimmune inflammatory rheumatic disease (AIRD) was greater among patients with a history of COVID-19 infection.
Go deeper with Google Headlines on:
Coagulation and inflammatory Covid-19 symptoms
[google_news title=”” keyword=”coagulation and inflammatory Covid-19 symptoms” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]